COMMUNIQUÉS West-GlobeNewswire

-
SRx Health Solutions Announces First Quarter 2025 Financial Results
15/05/2025 -
vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
15/05/2025 -
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
15/05/2025 -
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
15/05/2025 -
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
15/05/2025 -
Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update
15/05/2025 -
Dianabol (Dbol) For Sale 2025: Best Legal Dbol Pills, Cycles & Stacking Guide
15/05/2025 -
Best SARMs For Sale: Buy Legal SARMs For Bodybuilding & Cutting Cycles - Crazybulk
15/05/2025 -
Best Testosterone Booster for Men – Why TestoPrime is the Top Choice for Libido, Performance, and Vitality
15/05/2025 -
Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects
15/05/2025 -
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
15/05/2025 -
Arialief Criticism Reviewed: The Tainted Neuropathy Relief Controversy Published
15/05/2025 -
Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments
15/05/2025 -
Sanofi: Information concerning the total number of voting rights and shares - April 2025
15/05/2025 -
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2025
15/05/2025 -
Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
15/05/2025 -
vTv Therapeutics Announces Reinitiation of Screening in CATT1 Phase 3 Trial Evaluating Potential First-in-Class Liver-Selective Glucokinase Activator Cadisegliatin for Type 1 Diabetes
15/05/2025 -
Moana Beauty Spa Announces Advanced LED Facelift Protocol, Attracting International Clients to Waikiki for Non-Surgical Rejuvenation
15/05/2025 -
Dr. Jose Arnold Tariga from the USA Selected as Finalist for Aster Guardians Global Nursing Award 2025 Worth USD 250,000
15/05/2025
Pages